Moleculin Biotech (MBRX) Notes Payables (2015 - 2019)
Moleculin Biotech (MBRX) posted quarterly Notes Payables of $6.8 million for Q3 2019, up 1748.24% year-over-year from $369000.0 in Q3 2018, and down 1.79% quarter-over-quarter from $6.9 million in Q2 2019.
Moleculin Biotech (MBRX) Notes Payables (2015 - 2019) Analysis & Trends
Moleculin Biotech's Notes Payables history runs 5 years deep, the most recent figure standing at $6.8 million for Q3 2019.
- In Q3 2019, Notes Payables rose 1748.24% year-over-year to $6.8 million; the TTM figure through Sep 2019 stood at $6.8 million (up 1748.24% YoY), while the FY2018 annual figure was $180000.0, down 64.21% from the prior year.
- Notes Payables for Q3 2019 stood at $6.8 million, down from $6.9 million in the prior quarter.
- The five-year high for Notes Payables was $6.9 million in Q2 2019, with the low at $108000.0 in Q1 2017.
- The 5-year median for Notes Payables is $451000.0 (2018), against an average of $1.5 million.
- The sharpest annual moves came in 2017 and 2019: Notes Payables plunged 82.44% in 2017, then surged 1748.24% in 2019.
- Moleculin Biotech's Notes Payables stood at $450000.0 in 2015, then slumped by 33.85% to $297656.0 in 2016, then surged by 68.99% to $503000.0 in 2017, then slumped by 64.21% to $180000.0 in 2018, then jumped by 3688.89% to $6.8 million in 2019.
- Business Quant data shows MBRX's Notes Payables at $6.8 million in Q3 2019, $6.9 million in Q2 2019, and $2.4 million in Q1 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Moleculin Biotech | 3.35 Mn | 3.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 6.82 Mn |
| Jun 30, 2019 | 6.94 Mn |
| Mar 31, 2019 | 2.39 Mn |
| Dec 31, 2018 | 180,000.00 |
| Sep 30, 2018 | 369,000.00 |
| Jun 30, 2018 | 451,000.00 |
| Mar 31, 2018 | 463,000.00 |
| Dec 31, 2017 | 503,000.00 |
| Mar 31, 2017 | 108,000.00 |
| Sep 30, 2016 | 297,656.00 |
| Jun 30, 2016 | 431,644.00 |
| Mar 31, 2016 | 615,000.00 |
| Dec 31, 2015 | 450,000.00 |